Form 8-K - Current report:
SEC Accession No. 0000950103-25-007061
Filing Date
2025-06-05
Accepted
2025-06-05 16:04:11
Documents
13
Period of Report
2025-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K dp229762_8k.htm   iXBRL 8-K 61466
2 EXHIBIT 3.1 dp229762_0301.htm EX-3.1 255349
  Complete submission text file 0000950103-25-007061.txt   535674

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adct-20250603.xsd EX-101.SCH 3035
4 XBRL LABEL FILE adct-20250603_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE adct-20250603_pre.xml EX-101.PRE 22372
15 EXTRACTED XBRL INSTANCE DOCUMENT dp229762_8k_htm.xml XML 3765
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39071 | Film No.: 251027051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)